Ginsenoside compound K attenuates cognitive deficits in vascular dementia rats by reducing the Aβ deposition
Ginsenoside compound K (CK) is the main metabolite of protopanaxadiol-type ginsenosides and has been demonstrated to exert neuroprotective and cognition-enhancing effects. The effects of CK on cognitive function in vascular dementia (VD) has not been elucidated. Therefore, the present study aims to...
Saved in:
Main Authors: | Wenjing Zong (Author), Xiangchang Zeng (Author), Siyu Chen (Author), Lulu Chen (Author), Luping Zhou (Author), Xintong Wang (Author), Qing Gao (Author), Guirong Zeng (Author), Kai Hu (Author), Dongsheng Ouyang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway
by: Xiangchang Zeng, et al.
Published: (2018) -
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
by: Ye Zixin, et al.
Published: (2022) -
Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers
by: Lulu Chen, et al.
Published: (2018) -
Food and Sex-Related Impacts on the Pharmacokinetics of a Single-Dose of Ginsenoside Compound K in Healthy Subjects
by: Lulu Chen, et al.
Published: (2017) -
The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
by: Wenhui Liu, et al.
Published: (2021)